Jules Boscq, young French international ice hockey defender, has been suspended for 14 months by anti-doping, a spokesperson for the Court of Arbitration for Sport (CAS) confirmed to AFP on Wednesday.
The ECHL, a third-level North American professional hockey league, indicated Monday on its X account (formerly Twitter) that Boscq, new player for the Iowa Heartlanders (Coralville, United States), was suspended by his team for “ protect his rights to play in the ECHL.
The young 21-year-old defender explains on his social networks that he was convicted for a positive test dating from December 2021 for tuaminoheptane (molecule of the drug rhinofluimucil, a vasoconstrictor), a substance banned by the World Anti-Doping Agency and classified in the category stimulants.
First suspended for two months in June 2022 by the French Anti-Doping Agency (AFLD), Boscq indicates that he was sentenced more heavily by the CAS after the World Anti-Doping Agency (WADA) appealed the first sanction. .
“I took 2 or 3 nasal sprays the morning of the match to treat a persistent cold. I did not check the composition of this medicine, I was not careful. I will pay it in cash (...) I will be back next summer, completely free to resume the course of my career.
Tuaminoheptane, a molecule of the drug rhinofluimucil, a vasoconstrictor, is a substance banned by the World Anti-Doping Agency and classified in the category of stimulants.
Boscq, a former Bordeaux player, notably played in the 2023 Ice Hockey World Championships with the French team.